Clinical Trial Update: Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates dose finding and pharmacokinetics/pharmacodynamics of apatinib in advanced colorectal cancer. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED